JP2020517658A5 - - Google Patents

Download PDF

Info

Publication number
JP2020517658A5
JP2020517658A5 JP2019557434A JP2019557434A JP2020517658A5 JP 2020517658 A5 JP2020517658 A5 JP 2020517658A5 JP 2019557434 A JP2019557434 A JP 2019557434A JP 2019557434 A JP2019557434 A JP 2019557434A JP 2020517658 A5 JP2020517658 A5 JP 2020517658A5
Authority
JP
Japan
Prior art keywords
peptide
antibody
cancer
ecm
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019557434A
Other languages
English (en)
Japanese (ja)
Other versions
JP7419070B2 (ja
JP2020517658A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/028505 external-priority patent/WO2018195386A1/en
Publication of JP2020517658A publication Critical patent/JP2020517658A/ja
Publication of JP2020517658A5 publication Critical patent/JP2020517658A5/ja
Priority to JP2024001630A priority Critical patent/JP2024041874A/ja
Application granted granted Critical
Publication of JP7419070B2 publication Critical patent/JP7419070B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019557434A 2017-04-20 2018-04-20 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物 Active JP7419070B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024001630A JP2024041874A (ja) 2017-04-20 2024-01-10 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762487823P 2017-04-20 2017-04-20
US62/487,823 2017-04-20
PCT/US2018/028505 WO2018195386A1 (en) 2017-04-20 2018-04-20 Methods and compositions for treating cancer with ecm-affinity peptides linked to immunotherapeutic antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024001630A Division JP2024041874A (ja) 2017-04-20 2024-01-10 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物

Publications (3)

Publication Number Publication Date
JP2020517658A JP2020517658A (ja) 2020-06-18
JP2020517658A5 true JP2020517658A5 (https=) 2021-05-27
JP7419070B2 JP7419070B2 (ja) 2024-01-22

Family

ID=63856403

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019557434A Active JP7419070B2 (ja) 2017-04-20 2018-04-20 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物
JP2024001630A Pending JP2024041874A (ja) 2017-04-20 2024-01-10 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024001630A Pending JP2024041874A (ja) 2017-04-20 2024-01-10 免疫療法用抗体と連結させたｅｃｍ親和性ペプチドを用いてがんを処置するための方法および組成物

Country Status (7)

Country Link
US (2) US11574747B2 (https=)
EP (1) EP3612209A4 (https=)
JP (2) JP7419070B2 (https=)
CN (1) CN111132693A (https=)
AU (2) AU2018256453B2 (https=)
MX (1) MX2019012579A (https=)
WO (1) WO2018195386A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2889182A1 (en) * 2012-10-26 2014-05-01 The University Of Chicago Synergistic combination of immunologic inhibitors for the treatment of cancer
CN108623686A (zh) 2017-03-25 2018-10-09 信达生物制药(苏州)有限公司 抗ox40抗体及其用途
US11574747B2 (en) * 2017-04-20 2023-02-07 The University Of Chicago Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies
US11732029B2 (en) 2017-11-13 2023-08-22 The University Chicago Methods and compositions for the treatment of wounds
AU2019232729B2 (en) * 2018-03-05 2024-08-08 The University Of Chicago Methods and compositions for treating cancer with ECM-affinity peptides linked to cytokines
US11377488B2 (en) * 2018-07-03 2022-07-05 Catalent Pharma Solutions, Llc Multifunctional protein molecules comprising decorin and use thereof
CN113710229B (zh) * 2019-02-25 2026-01-06 芝加哥大学 用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
WO2020247973A1 (en) * 2019-06-03 2020-12-10 The University Of Chicago Methods and compositions for treating cancer with cancer-targeted adjuvants
CA3165384A1 (en) * 2019-12-19 2021-06-24 Board Of Regents, The University Of Texas System Methods for treating glioblastoma
CN115065734A (zh) * 2021-02-27 2022-09-16 华为技术有限公司 一种数据处理方法、装置及芯片
WO2025203029A1 (en) * 2024-03-28 2025-10-02 Hadasit Medical Research Services And Development Ltd. Tricer - a tri-specific cell engager and retainer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654270A (en) * 1988-06-28 1997-08-05 La Jolla Cancer Research Foundation Use of fibromodulin to prevent or reduce dermal scarring
AU6934600A (en) * 1999-08-27 2001-03-26 Board Of Regents, The University Of Texas System Cd40 ligand and cd40 agonist compositions and methods of use
NZ522971A (en) * 2000-05-05 2005-02-25 Gtc Biotherapeutics Inc Transgenically produced decorin in the mammary gland of a transgenic animal
US20080160024A1 (en) * 2006-12-07 2008-07-03 Board Of Trustees Of The University Of Arkansas Inhibition of cancer metastasis
AT504685B1 (de) * 2006-12-20 2009-01-15 Protaffin Biotechnologie Ag Fusionsproteine
WO2011060242A2 (en) 2009-11-13 2011-05-19 Talecris Biotherapeutics, Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
US9879062B2 (en) * 2012-07-03 2018-01-30 Ecole Polytechnique Federale De Lausanne Protein-binding peptide isolated from placenta growth factor
WO2016054107A1 (en) * 2014-09-29 2016-04-07 Counterpoint Biomedica Llc Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polymers
KR20170066546A (ko) * 2014-10-03 2017-06-14 노파르티스 아게 조합 요법
US10786547B2 (en) 2015-07-16 2020-09-29 Biokine Therapeutics Ltd. Compositions, articles of manufacture and methods for treating cancer
US11574747B2 (en) * 2017-04-20 2023-02-07 The University Of Chicago Methods of treating cancer with placenta growth factor peptide linked to immunotherapeutic antibodies

Similar Documents

Publication Publication Date Title
JP2020517658A5 (https=)
Fallon et al. The immunocytokine NHS-IL12 as a potential cancer therapeutic
JP6858558B2 (ja) 新生物疾患の処置、減少、阻害、又は制御において使用するための、免疫調節薬
JP2023524530A (ja) 免疫原性が低い癌の癌細胞死滅を増強するための３剤併用療法
EP3328363A1 (en) Compositions and methods for immunomodulation
JP2021514661A5 (https=)
JP2016527286A5 (https=)
JP2019526578A (ja) キャリアー−ｐｄ−ｌ１結合剤組成物及び癌を処置する為にそれを使用する方法
US20220008515A1 (en) Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor
JP6892443B2 (ja) がん治療で使用するためのチェックポイント阻害剤及び全細胞マイコバクテリウム
JP7139293B2 (ja) Ｇｄ２陽性がんを処置するための製剤および方法
CN103536917B (zh) 干扰素在治疗肿瘤中的用途及相关的产品和方法
WO2021068196A1 (en) Methods of using il-33 protein in treating cancers
Dianat-Moghadam et al. Immunotherapies targeting tumor vasculature: challenges and opportunities
US20220249621A1 (en) TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINS
JP2020528449A5 (https=)
JP2011506436A (ja) 細胞傷害性ｔリンパ球抗原４（ｃｔｌａ４）に対する抗体と組み合わせられたアルファチモシンペプチドによる黒色腫の処置の方法
WO2020243603A1 (en) Dosing of bispecific t cell engager
US20240216554A1 (en) Radioimmunoconjugates directed to nkg2d ligands for the treatment of cancer
US11419894B2 (en) Modified natural killer cells for the treatment of cancer
TWI812820B (zh) 使用先天性免疫修飾劑及ox40促效劑治療疾病之組合療法
KR20170090406A (ko) 펩타이드-단백질 콘주게이트를 이용한 종양의 치료
US20210130456A1 (en) Single-chain variable fragment of met monoclonal antibody and methods of use in car t cell therapy
CN102935228B (zh) 用于肿瘤治疗的试剂、其用途及方法
AU2022253906A1 (en) Dosing of bispecific t cell engager